"DXB's potential market of USD $6bil versus NEU's potential market of USD $0.52bil. That is a huge difference"
Noting that this slightly exaggerates the difference in that the FSGS forecast is for 2032 and the Retts forecast is for 2029. Based on the current FSGS market potential of $3B and linear growth, the forecast 2029 fig for FSGS is $5B - still 10 times more!
Also noting that NEU has several other targets - as does DXB.
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma, page-123
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.035(6.67%) |
Mkt cap ! $308.1M | |||
| Open | High | Low | Value | Volume |
| 51.5¢ | 57.3¢ | 50.5¢ | $2.179M | 3.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30558 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |